Leaderboard

En | De
No articles selected!     View Cart  
You are here: Psychiatry » Schizophrenia and Psychotic Disorders 05. August 2026
Search
medline.ch
Schizophrenia and Psychotic Disorders
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Anxiety Disorders
Dementia
Depressive Disorders
Eating Disorders
Personality Disorders
Schizophrenia and Psychotic Disorders
Sleep Disorders
Sexual Disorders
Somatoform Disorders
Substance-Related Disorders
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3475  Previews Next
   
   Articles 1 - 20 / 69499  
   
Accelerated, Neuronavigated Neuromodulation for Negative Symptoms in Schizophrenia: Protocol for a Randomized Controlled Pilot Trial.
Sante Ment Que
Choucroun A, Roy O, Potvin S, Palaniyappan L, Zeramdini N, Aiyaar A, Picard K, Zanjani S, Parekh D, Markessinis M, Friesen T, Zamorano T, Diaconescu A, Lepage M, Powers A, Shah J, Zavaglia E, Benrimoh D.
PMID: 42550441 [PubMed - indexed for MEDLINE]


[Spirituality and cortisol in people living with schizophrenia: An exploratory study].
Sante Ment Que
Poulin A, Lupien S, Consortium Signature.
PMID: 42550433 [PubMed - indexed for MEDLINE]


Efficacy and safety of add-on topiramate vs. metformin on cardiometabolic profile in patients of schizophrenia on atypical antipsychotics with metabolic syndrome: an active-controlled, rater-blinded, parallel-design randomized controlled trial.
Eur Arch Psychiatry Clin Neurosci
Chakraborty R, Mohapatra D, Biswas T, Ramasubbu MK, Maiti R, Mishra A, Mishra BR.
PMID: 42550195 [PubMed - as supplied by publisher]


Investigating changes in the blood-brain barrier in schizophrenia spectrum disorders: design and methodology of a longitudinal dynamic contrast-enhanced MRI study.
Eur Arch Psychiatry Clin Neurosci
Wendl A, Zöllinger A, Lukas D, Lutz I, Schamberger M, Lobinger C, Maurus I, Hasan A, Wagner E, Falkai P, Schmitt A, Raabe FJ, Schiltz K, Seelos K, Stöcklein S, Boudriot E, Yakimov V, Roell L, Keeser D, Moussiopoulou J.
PMID: 42550194 [PubMed - as supplied by publisher]


Untreated Psychosis and Healthcare-Seeking Behaviour in Pakistan: A Qualitative Study With Young People, Carers, Traditional Healers, and Healthcare Professionals.
Early Interv Psychiatry
Sanauddin N, Dikomitis L, Khan AJ, Azeemi MMUH, Khan MF, Sheikh S, Fonseka N, Milner A, Shah SMU, Azeemi IT, Hamid S, Jamal SF, Sargeant A, Farooq S.
PMID: 42549551 [PubMed - indexed for MEDLINE]


Anorexia Nervosa, Schizophrenia, and Autism Spectrum Disorder: A Review of the Role of Tanycytes in Individual and Social Behavior.
Cureus
Dalvi P, Kelly O, Grady L, Carris N, Sullivan J, Liu H.
PMID: 42549257 [PubMed]


Trial-History Effects During WCST in Treatment-Resistant Schizophrenia.
Neuropsychopharmacol Rep
Sawagashira R, Toyomaki A, Watanabe H, Hashimoto N, Kato TA.
PMID: 42548112 [PubMed - indexed for MEDLINE]


Real-world antipsychotic prescribing patterns and mortality in schizophrenia: a registry cohort study from China.
Epidemiol Psychiatr Sci
He H, Dai L, Ma S, Jia FJ, Chen B, Lin H, Wang SB, Tan W, Li J.
PMID: 42548073 [PubMed - indexed for MEDLINE]


High prevalence of tau pathologies in late-onset psychosis: A PET study.
Mol Psychiatry
Kubota M, Kurose S, Tagai K, Momota Y, Ichihashi M, Endo H, Seki C, Moriguchi S, Yamamoto Y, Kataoka Y, Goto R, Tamura T, Shiwaku H, Matsuoka K, Suzuki H, Onaya M, Tokuda T, Uchida H, Takahashi H, Kawamura K, Zhang MR, Higuchi M, Takahata K.
PMID: 42547799 [PubMed - as supplied by publisher]


Neuroinflammatory pathways linking pain and rehabilitation outcomes in schizophrenia: a narrative review.
Pain Manag
Sedghi Esfahani S, Mahdinia E, Dehkhodaei S, Abedi Oumali N, Taherkhani S, Rafaiee R.
PMID: 42547491 [PubMed - as supplied by publisher]


Adjunctive Nutritional Interventions in Schizophrenia: A Systematic Review of Randomised Clinical Trials.
Clin Nutr ESPEN
Braga Conceição B, Arruda de Brito TR, Santos Reis CNSD, Theophilo Teixeira J, Botelho BCRP, Souza Cardoso F.
PMID: 42547027 [PubMed - as supplied by publisher]


Methodological Concerns in a Recently Published Systematic Review and Meta-Analysis of Xanomeline-Trospium in Schizophrenia : Re: Azargoonjahromi A, Nasiri H. Efficacy and Safety of KarXT (Xanomeline-Trospium; Cobenfyâ„¢) in Schizophrenia: A Systematic and Meta-Analysis Review of Randomized Controlled Trials. Psychiatric Quarterly. 2025. https://doi.org/10.1007/s11126-025-10226-7.
Psychiatr Q
Dhale A, Dharaiya D.
PMID: 42543467 [PubMed - as supplied by publisher]


Meeting Family Education and Support Needs in the Early Psychosis Context: Description and Evaluation of a Pragmatic Family Program.
Early Interv Psychiatry
Holland M, Parker S, Sanders N, Flear J, Clarkson T, Burke K.
PMID: 42543197 [PubMed - indexed for MEDLINE]


Potential preventive role of low-dose methotrexate against incident recorded psychosis: a retrospective cohort study based on electronic health records.
EClinicalMedicine
Corsi-Zuelli F, Taquet M, Deakin B, Upthegrove R.
PMID: 42542620 [PubMed]


Peripheral toll-like receptor expression indicates distinct innate immune signatures in schizophrenia spectrum and mood disorders: A systematic review and meta-analysis.
Brain Behav Immun
Karska J, Kowalski S, Rudy K, Szyszka M, Lewicka W, Enrico P, Drexhage H, Pawlak E, Piotrowski P, Misiak B.
PMID: 42542193 [PubMed - as supplied by publisher]


Corrigendum to "Validation of the SPF-10: A new scale for assessing self-perceived functioning in schizophrenia. The VALFASS study" [J. Psychiatr. Res. 201 (2026) 526-538].
J Psychiatr Res
Garcia Portilla MP, San Miguel PS, Corripio I, Fraguas D, Olivares JM, Alvarez NC, Cansado AL, Amoretti S, Lahera G, Vieta E, Moreno MJ, Cornella M, Bioque M.
PMID: 42542091 [PubMed - as supplied by publisher]


Psychosis in the Age of Large Language Models (LLMs): A Narrative Review of the Proposed Construct of AI-Induced Psychosis.
Cureus
Tong TX, Gong ZZ, Yao SY.
PMID: 42540500 [PubMed]


Oestrogen modulators as augmentation to antipsychotics for the treatment of post- and perimenopausal psychosis: a systematic review.
Ther Adv Psychopharmacol
Keen C, Hassoulas A, Richardson J.
PMID: 42540040 [PubMed]


Schizophrenia Beyond Genome-Wide Association Studies: It's About Time.
Am J Psychiatry
Pergola G, Weinberger DR.
PMID: 42538589 [PubMed - indexed for MEDLINE]


Efficacy and Safety of Alpha-Lipoic Acid as an Adjunctive Therapy in Schizophrenia: A Systematic Review and Meta-Analysis.
J Clin Psychopharmacol
Tudella GCN, Pereira MAOM, Klostermann AU, Gonzalez JVP, Gonçalves OR, Donato KO, Nantes LAO, da Silva AMP, Forte ARCC, Patrocínio MLV, de Queiroz Oliveira T, Vasconcelos SMM.
PMID: 42535603 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 69499    Page 1 of 3475  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1